SCHEMBL6174186

SCHEMBL6174186

Cc1ccc2c(CC3(C)NC(=O)N(c4ccc(S(=O)(=O)C(F)(F)F)cc4)C3=O)ccnc2c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 2/20 0.51
KMT2A Q03164 2/20 0.40
AR P10275 6/20 0.39
TP53 P04637 2/20 0.38
POLB P06746 1/20 0.33
ITGAL P20701 1/20 0.33
THRB P10828 1/20 0.32
LMNA P02545 4/20 0.32
HTT P42858 2/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
MEN1 O00255 1/20 0.32
CYP1A2 P05177 1/20 0.32
PGR P06401 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C9 P11712 1/20 0.32
TSHR P16473 1/20 0.32
ALOX12 P18054 1/20 0.32
NFKB1 P19838 1/20 0.32
CYP2C19 P33261 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6172546 0.89 IGF1R (0.49) IGF1RKMT2AARTP53ITGAL
SCHEMBL6171503 0.88 IGF1R (0.65) IGF1RKMT2AARTP53ITGAL
SCHEMBL6175292 0.88 IGF1R (0.65) IGF1RKMT2AARTP53ITGAL
SCHEMBL6250335 0.86 IGF1R (0.51) IGF1RKMT2AARTP53ITGAL
SCHEMBL6173279 0.84 IGF1R (0.50) IGF1RKMT2AARTP53ITGAL
SCHEMBL6173786 0.84 IGF1R (0.50) IGF1RARTHRBLMNACYP3A4
Trifluoroacetic Acid SCHEMBL17558350 0.84 IGF1R (0.60) IGF1RKMT2AARITGALLMNA
Trifluoroacetic Acid SCHEMBL17558459 0.84 IGF1R (0.60) IGF1RKMT2AARITGALLMNA
SCHEMBL6175236 0.83 IGF1R (0.50) IGF1RKMT2AARTP53ITGAL
SCHEMBL6172368 0.83 IGF1R (0.52) IGF1RKMT2AARTP53ITGAL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed